Robotic anatomic pulmonary resection-the data

Robot-assisted pulmonary resection, specifically robotic-assisted lobectomy (RL), has gained increasing popularity worldwide due to its high-resolution three-dimensional visualization and precise wristed instrumentation. This adoption aligns with current society guidelines recommending minimally invasive resection for early-stage lung cancer. RL serves as an excellent alternative to thoracoscopic or open approaches, and this article reviews the comprehensive data available on RL. This review gathered papers that examined and compared the outcomes, lymph node yield, cost, and survival associated with open lobectomy (OL), video-assisted thoracoscopic surgery (VATS) lobectomy, and RL. With a specific focus on the outcomes of RL, including its impact on perioperative outcomes, cost-effectiveness, lymph node yield, and long-term survival. Existing data suggest that RL offers numerous advantages, such as reduced complications, minimal blood loss, shorter hospital stays, and lower conversion rates to open surgery compared to traditional OL. Furthermore, RL exhibits improved lymph node yield and equivalent long-term survival outcomes, further supporting its efficacy. As RL continues to evolve, the need for ongoing research becomes increasingly important. This includes conducting randomized clinical trials (RCTs) to refine our understanding of RL and further enhance patient outcomes. With a focus on accumulating and analyzing contemporary data, this article underscores the continuous progression of RL within the field of roboticassisted pulmonary resection.